MITF

MITF antibody LS-C390645 is an unconjugated mouse monoclonal antibody to human MITF (N-Terminus). Validated for IHC and WB.

Antibodies Primary

Article No

LS-C390645-100

Species Reactivity

human

Size

100 µg

Clone

d5

Source / Host

mouse

Shipping Information

RT

Application

IHC, WB

Article No

LS-C390645-100

Species Reactivity

human

Size

100 µg

Clone

d5

Source / Host

mouse

Shipping Information

RT

Application

IHC, WB

Specifications

NCBI Number 4286
Application IHC, WB
Article No LS-C390645-100
Country Availability SE, FI, DK, NO, FO, GL
Clone d5
Clone Type monoclonal
Concentration 0.2 mg/ml
Conjugation Unconjugated
Description MITF antibody LS-C390645 is an unconjugated mouse monoclonal antibody to human MITF (N-Terminus). Validated for IHC and WB.
Recommended Dilution IHC-P (0.5 - 1 ug/ml)
Supplier LifeSpan Biosciences
Entrez Gene ID 4286
Gene Symbol MITF
Immunogen An N-Terminus fragment of human Mi protein.
Isotype IgG1 k
Notes MITF antibody LS-C390645 is an unconjugated mouse monoclonal antibody to human MITF (N-Terminus). Validated for IHC and WB.
Alias Names MITF, BHLHe32, CMM8, MI, Waardenburg syndrome, type 2A, WS2, WS2A
Product Type Antibodies Primary
Protocol MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. Anti-MITF, D5, recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. Optimal dilution of the MITF antibody should be determined by the researcher. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
Purification Protein G Purified
Shipping Information RT
Size 100 µg
Source / Host mouse
Species Reactivity human
Storage 4°C
Substrate / Buffer 0.01% BSA, 0.05% sodium azide
Technical Specifications Human MITF
Product Page Updated 2024-04-12T09:20:06.597Z

Suggested protocols

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more